![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Demitrack Mark A
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.7, Iss.3, 2006-04, pp. : 521-528
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Vernon Suzanne D Reeves William C
Pharmacogenomics, Vol. 7, Iss. 3, 2006-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 7, 2015-01 ,pp. :